| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Interest income and other income, net | 306 | 2,096 | 713 | 979 |
| Net loss before income taxes | -15,446 | -13,548 | -22,930 | -11,509 |
| Net loss | -15,446 | -13,548 | -22,930 | -11,509 |
| Comprehensive loss | -15,446 | -13,548 | -22,930 | -11,509 |
| Basic (in dollars per share) | -0.14 | -0.14 | -0.24 | -0.13 |
| Basic (in shares) | 110,584,371 | 99,326,701 | 95,497,056 | 91,082,081 |
| Diluted (in dollars per share) | -0.14 | -0.14 | -0.24 | -0.13 |
| Diluted (in shares) | 110,584,371 | 99,326,701 | 95,497,056 | 91,082,081 |
Aquestive Therapeutics, Inc. (AQST)
Aquestive Therapeutics, Inc. (AQST)